Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE American - Delayed Quote USD

Calidi Biotherapeutics, Inc. (CLDI)

0.4973
+0.0172
+(3.58%)
At close: April 24 at 4:00:00 PM EDT
0.4750
-0.02
(-4.48%)
After hours: April 24 at 6:00:57 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for CLDI

Recent News: CLDI

View More
Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director

Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director
GlobeNewswire yesterday
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
GlobeNewswire 2 days ago
Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors
GlobeNewswire 7 days ago
Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor
GlobeNewswire 14 days ago
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
GlobeNewswire 24 days ago
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
GlobeNewswire 24 days ago
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
GlobeNewswire 27 days ago
Calidi Biotherapeutics and City of Hope Provide Update on a Phase 1 Clinical Trial with CLD-101 Virotherapy in Patients with Recurrent High-Grade Glioma

Calidi Biotherapeutics and City of Hope Provide Update on a Phase 1 Clinical Trial with CLD-101 Virotherapy in Patients with Recurrent High-Grade Glioma
GlobeNewswire 29 days ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ACCESS Newswire last month
IBN Coverage: Calidi Biotherapeutics (NYSE American: CLDI) Reports Promising Preclinical Results for RTNova Virotherapy Platform

IBN Coverage: Calidi Biotherapeutics (NYSE American: CLDI) Reports Promising Preclinical Results for RTNova Virotherapy Platform
NewMediaWire last month
Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform
GlobeNewswire last month
View More

Related Tickers

ALGS Aligos Therapeutics, Inc.
5.83
+8.77%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9000
+4.32%
 
BIVI BioVie Inc.
0.8941
+6.42%
 
SGMT Sagimet Biosciences Inc.
3.1200
+12.43%
 
ACXP Acurx Pharmaceuticals, Inc.
0.4017
+3.80%
 
RENB Renovaro Inc.
0.3728
-0.75%
 
CANF Can-Fite BioPharma Ltd.
1.1700
-0.85%
 
ENLV Enlivex Therapeutics Ltd.
0.9600
+4.35%
 
SLXNW Silexion Therapeutics Corp
0.0367
-47.42%
 
ALLR Allarity Therapeutics, Inc.
1.0700
+5.94%